Research | Center for Healthcare Policy and Research | UC Davis Health

This $6.4 million study is led by Stephen Henry, a professor of internal medicine, and sponsored by Patient-Centered Outcomes Research Institute. The study compares rates of establishing outpatient opioid use disorder treatment to determine whether patients referred to telehealth treatment versus in-person treatment have better patient outcomes and experiences. 

This $4 million clinical trial is led by Michelle Dossett, associate professor of internal medicine, and sponsored by the National Institutes of Health's (NIH) National Institute of Aging. This clinical trial seeks to understand the characteristics of clinic visits that affect health outcomes for patients with knee osteoarthritis using topical diclofenac gel. 

This $1 million grant from the Centers for Disease Control and Prevention is led by Joshua Fenton, a professor of family and community medicine. The project seeks to help address the opioid overdose crisis by assessing CA Bridge, an initiative to expand medication for addiction treatment in emergency departments. Our staff provide patient recruitment and qualitative methodology expertise. 

This $5.6 million clinical trial is led by Stephen Henry, a professor of internal medicine, and sponsored by National Institutes of Health’s National Institute of Drug Abuse. This study will advance efforts to improve long-term buprenorphine treatment rates for low-income and other vulnerable patients who disproportionately seek opioid use disorder care in emergency departments.  

This $1.5 million project is led by Michelle Dossett, associate professor of internal medicine, and sponsored by Brigham and Women's Hospital and the National Institutes of Health (NIH). This project addresses the critical gaps and multiple variables that directly impact bilingualism and cognitive reserve and progression of Alzheimer's disease and related dementias with three specific aims. 

This $1 million study is led by Joshua Fenton, a professor of family and community medicine, and funded by the Centers for Disease Control and Prevention. This study identifies the risk and protective factors connected to the combination of opioids and benzodiazepines use, a group of drugs used to treat anxiety and insomnia. 

This $575,050 project is led by professor and family medicine physician Na'amah Razon and funded by the National Institutes of Health's National Institute of Diabetes, Digestive and Kidney Diseases. It assesses how different modes of transportation can impact patient access to hemodialysis. Razon and Bethney Bonilla from the Center for Healthcare Policy and Research discussed their work in a podcast with the National Kidney Foundation (NKF).